» Articles » PMID: 9439405

Interstitial Photodynamic Therapy in the Canine Prostate

Overview
Journal Br J Urol
Specialty Urology
Date 1998 Jan 24
PMID 9439405
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine the depth of tissue destruction and the minimum light dose required for necrosis in interstitial photodynamic therapy (PDT), as a prerequisite for the investigational therapy of patients.

Materials And Methods: Seven adult beagle dogs were given 2 mg/kg of the photosensitizer Photofrin intravenously and two controls received none. After 24 h, 450 J/cm of 630 nm wavelength laser light was delivered interstitially to the prostate via a 2 cm long diffuser fibre. Seven single-fibre treatments were performed in five sensitized dogs and two single-fibre treatments in the controls. The two remaining sensitized dogs had two fibres placed 10 mm apart within the prostate to determine the coalescence of PDT lesions. The penetration depth of light was measured in all prostates, and after PDT the extent of necrosis was assessed histologically.

Results: The mean (standard deviation, SD) radius of PDT destruction around each diffuser was 5.3 (1.4) mm and PDT lesions overlapped in prostates treated with two fibres placed 10 mm apart. There was no observable tissue damage in the controls. The mean (SD) minimum light dose required for PDT necrosis was 84 (64) J/cm2. Differences among animals in the light penetration depth were small, with a mean of 2.14 (0.2) mm, and did not correlate with the depth of necrosis (P = 0.07). Bleeding around the optical diffuser fibre impeded light penetration.

Conclusion: Interstitial PDT in the canine prostate using Photofrin produced modest volumes of tissue necrosis. The minimum light dose required to induce necrosis was variable because bleeding was unpredictable in relation to the optical fibre.

Citing Articles

Photodynamic Diagnosis and Therapy for Peritoneal Carcinomatosis from Gastrointestinal Cancers: Status, Opportunities, and Challenges.

Kim H, Wilson B J Gastric Cancer. 2021; 20(4):355-375.

PMID: 33425438 PMC: 7781745. DOI: 10.5230/jgc.2020.20.e39.


Singlet oxygen model evaluation of interstitial photodynamic therapy with 5-aminolevulinic acid for malignant brain tumor.

Izumoto A, Nishimura T, Hazama H, Ikeda N, Kajimoto Y, Awazu K J Biomed Opt. 2019; 25(6):1-13.

PMID: 31838789 PMC: 7013325. DOI: 10.1117/1.JBO.25.6.063803.


Automatic interstitial photodynamic therapy planning via convex optimization.

Yassine A, Kingsford W, Xu Y, Cassidy J, Lilge L, Betz V Biomed Opt Express. 2018; 9(2):898-920.

PMID: 29552420 PMC: 5854086. DOI: 10.1364/BOE.9.000898.


On the in vivo photochemical rate parameters for PDT reactive oxygen species modeling.

Kim M, Ghogare A, Greer A, Zhu T Phys Med Biol. 2017; 62(5):R1-R48.

PMID: 28166056 PMC: 5510640. DOI: 10.1088/1361-6560/62/5/R1.


Optimization of light sources for prostate photodynamic therapy.

Altschuler M, Zhu T, Li J, Hahn S Proc SPIE Int Soc Opt Eng. 2015; 5689:186-197.

PMID: 26136612 PMC: 4484893. DOI: 10.1117/12.590343.